Dihydropyridine Ca(2+) channel blockers increase cytosolic [Ca(2+)] by activating Ca(2+)-sensing receptors in pulmonary arterial smooth muscle cells.
作者:
主题词
动物(Animals);钙通道阻滞药(Calcium Channel Blockers);钙通道, L型(Calcium Channels, L-Type);钙信号(Calcium Signaling);细胞, 培养的(Cells, Cultured);胞质溶胶(Cytosol);疾病恶化(Disease Progression);人类(Humans);高血压, 肺性(Hypertension, Pulmonary);肌醇磷酸类(Inositol Phosphates);男(雄)性(Male);野百合碱(Monocrotaline);肌细胞, 平滑肌(Myocytes, Smooth Muscle);萘类(Naphthalenes);硝苯地平(Nifedipine);肺动脉(Pulmonary Artery);大鼠(Rats);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);受体, 钙敏感(Receptors, Calcium-Sensing);重组融合蛋白质类(Recombinant Fusion Proteins);信号传导(Signal Transduction);转染(Transfection);增量调节(Up-Regulation);血管收缩(Vasoconstriction)
DOI
10.1161/CIRCRESAHA.113.300897
PMID
23300272
发布时间
2021-10-21
- 浏览6

Circulation research
640-50页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文